FOR REMOTE PATIENT MONITORING
RESP® Biosensor
Enhance your patient monitoring capabilities from hospital to home
FDA 510(k) Class II | CE Mark | HIPAA Compliant

Technology Overview
The RESP® Biosensor offers clinicians and healthcare teams a first-of-its-kind technology to advance respiratory disease surveillance and management.
- Continuous and passive lung sound monitoring to extend the range of stethoscope auscultation and in-person assessments¹
- Patient-friendly form factor that respects patient comfort and lifestyle.
- Physiological data including heart rate*, heart rate variability*, and respiratory rate*
*Measurement not yet FDA cleared
1. Equivalent performance to 3M Littman 3200 Electronic Stethoscope (source)

OVERVIEW VIDEO
“With this information we can predict if the patient is doing better or worse and intervene ahead of time to prevent the patient from having major complications”
– Sadia Benzaquen, MD, Chair of Pulmonary Critical Care, Einstein Medical Center
Track Patient Progress Objectively and Remotely
KEY FEATURES
- Passive & continuous
- Notifications for clinical deterioration
- HIPAA compliant
- Reimbursable under RTM & RPM codes
- 24+ hour battery life & rechargeable
- EHR/telehealth integration
- Flexible reporting of lung sounds including automated* and manual options
*Machine learning algorithms not FDA cleared
Lung sound recordings captured by the biosensor are depicted visually as spectrograms
Cough
Wheeze
Crackles
Interested in a Research Collaboration?
We’re seeking clinical and academic collaborators to explore how wearable respiratory technologies can improve patient outcomes. Partners may be eligible for in-kind support.
RESP® Biosensor Care Settings
Ambulatory Care
- Remote monitoring of at-risk COPD & Asthma patients
- Interstitial lung diseases
- Heart failure
- Pulmonary Rehabilitation
Acute Care
- In-patient status monitoring
- Chronic, complex care management
- Hospital at Home
- Tele-ICUs
Post-Acute Care
- Post-discharge hospital to home
- Post-surgical recovery and rehabilitation
- Skilled-nursing and long-term care facilities
Practice Application
Patient is prescribed RESP® Biosensor for two weeks
On day 5, clinician receives alert of increased coughing and wheezing
Clinician checks in with patient virtually and adjusts treatment plan to avoid a readmission
Publications
View our clinical validation, whitepapers and case studies
Increasing Abnormal Lung Sounds After Discharge Predicts COPD Readmission
Poster Presentation, CHEST, 2023
Remote Auscultation At Home After Asthma Exacerbation: A Case from Discharge to Readmission
Poster Presentation, American Thoracic Society, 2020
Talk to our Team
Reach out to explore using the RESP Biosensor in your practice